Related Experiment Videos
Dose adjustment in patients with liver disease
Fabiola Delcò1, Lydia Tchambaz, Raymond Schlienger
1Division of Gastroenterology, University Hospital of Basel, Switzerland.
Drug Safety
|June 1, 2005
Summary
Drug dosing in liver disease requires careful consideration of hepatic extraction. Dose adjustments are crucial for high and intermediate extraction drugs, while low extraction drugs need reduced maintenance doses. Renal function also impacts drug clearance in cirrhotic patients.
Area of Science:
- Pharmacology
- Hepatology
- Clinical Pharmacy
Background:
- No endogenous marker exists for hepatic clearance, complicating drug dosing in liver disease.
- Liver cirrhosis and cholestasis significantly alter drug pharmacokinetics, affecting bioavailability and clearance.
- Renal function impairment in cirrhotic patients, even with normal creatinine, necessitates dose adjustments for renally eliminated drugs.
Purpose of the Study:
- To provide guidance on drug dose adaptation in patients with liver disease, specifically cirrhosis and cholestasis.
- To categorize drugs based on hepatic extraction to predict kinetic behavior in cirrhotic patients.
- To highlight the importance of monitoring drug effects and toxicity due to altered pharmacokinetics and pharmacodynamics.
Main Methods:
- Grouping drugs based on their hepatic extraction extent (high, intermediate, low).
- Analyzing the impact of liver disease on drug bioavailability and clearance.
- Considering biliary and renal elimination pathways for dose adjustments.
Main Results:
- High hepatic extraction drugs require reduced initial oral and maintenance doses in cirrhotic patients.
- Low hepatic extraction drugs necessitate reduced maintenance doses based on decreased hepatic metabolism.
- Intermediate hepatic extraction drugs need cautious initial dosing and reduced maintenance doses.
- Biliary eliminated drugs in cholestasis and renally eliminated drugs in cirrhosis require specific dose adaptations and close monitoring.
Conclusions:
- Drug dosing in liver disease is complex and requires individualized strategies based on drug properties and patient condition.
- Accurate dose adaptation for drugs with high hepatic extraction, low hepatic extraction, and intermediate hepatic extraction is essential.
- Clinical monitoring for pharmacological effects and toxicity is paramount, especially for drugs with predominant renal elimination or altered pharmacodynamics.